Prognostic Value of Different Metabolic Measurements with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Resectable Non-Small Cell Lung Cancer: A Two-Center Study
Open Access
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (11) , 1007-1012
- https://doi.org/10.1097/jto.0b013e31815608f5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The prognostic value of positron emission tomography in non-small cell lung cancer: Analysis of 266 casesLung Cancer, 2006
- [18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose UseJournal of Clinical Oncology, 2003
- Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancerNuclear Medicine Communications, 2002
- [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer✩European Journal of Cardio-Thoracic Surgery, 2000
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- The international system for staging lung cancerSeminars in Surgical Oncology, 2000
- Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 CasesJournal of Clinical Oncology, 1999
- The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinomaCancer, 1998